BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8772597)

  • 1. Growth hormone does not increase thyroid size in the absence of thyrotropin: a study in adults with hypopituitarism.
    Cheung NW; Lou JC; Boyages SC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1179-83. PubMed ID: 8772597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism.
    Jørgensen JO; Pedersen SA; Laurberg P; Weeke J; Skakkebaek NE; Christiansen JS
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1127-32. PubMed ID: 2685007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study.
    Curtò L; Giovinazzo S; Alibrandi A; Campennì A; Trimarchi F; Cannavò S; Ruggeri RM
    Eur J Endocrinol; 2015 May; 172(5):543-52. PubMed ID: 25646405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid function during growth hormone therapy.
    Jørgensen JO; Møller J; Skakkebaek NE; Weeke J; Christiansen JS
    Horm Res; 1992; 38 Suppl 1():63-7. PubMed ID: 1295815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of growth hormone replacement on the thyroid axis in patients with hypopituitarism: in vivo and ex vivo studies.
    Glynn N; Kenny H; Quisenberry L; Halsall DJ; Cook P; Kyaw Tun T; McDermott JH; Smith D; Thompson CJ; O'Gorman DJ; Boelen A; Lado-Abeal J; Agha A
    Clin Endocrinol (Oxf); 2017 May; 86(5):747-754. PubMed ID: 27809356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: comparison with growth hormone.
    Hussain MA; Schmitz O; Jorgensen JO; Christiansen JS; Weeke J; Schmid C; Froesch ER
    Eur J Endocrinol; 1996 May; 134(5):563-7. PubMed ID: 8664976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels.
    Miyakawa M; Saji M; Tsushima T; Wakai K; Shizume K
    J Clin Endocrinol Metab; 1988 Nov; 67(5):973-8. PubMed ID: 3053751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid function in non-growth hormone-deficient short children during a placebo-controlled double blind trial of recombinant growth hormone therapy.
    Rose SR; Leong GM; Yanovski JA; Blum D; Heavner G; Barnes KM; Chipman JJ; Dichek HL; Jacobsen J; Klein KE
    J Clin Endocrinol Metab; 1995 Jan; 80(1):320-4. PubMed ID: 7829634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males.
    Fisker S; Nørrelund H; Juul A; Skakkebaek NE; Christiansen JS; Jørgensen JO
    Growth Horm IGF Res; 2001 Apr; 11(2):104-9. PubMed ID: 11472076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and thyroid function in children treated with growth hormone.
    Pirazzoli P; Cacciari E; Mandini M; Sganga T; Capelli M; Cicognani A; Gualandi S
    J Pediatr; 1992 Aug; 121(2):210-3. PubMed ID: 1640285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
    Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
    J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
    Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy.
    Russell-Jones DL; Weissberger AJ; Bowes SB; Kelly JM; Thomason M; Umpleby AM; Jones RH; Sönksen PH
    Acta Endocrinol (Copenh); 1993 Jun; 128 Suppl 2():44-7. PubMed ID: 8342393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury.
    Leal-Cerro A; Flores JM; Rincon M; Murillo F; Pujol M; Garcia-Pesquera F; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 2005 May; 62(5):525-32. PubMed ID: 15853820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.